$COPHF News: Creso Pharma and Red Light Holland Me
Post# of 10141
(Total Views: 172)
Posted On: 06/23/2021 9:57:00 AM
$COPHF News: Creso Pharma and Red Light Holland Merge to Introduce The HighBrid Lab (TM), a Leading Global Psychedelics x Cannabis Company, Specializing in Recreational Products, Applied Science, Technology and Innovation
Click here:
https://stockhouse.com/news/press-releases/20...d-lab-tm-a
About Creso Pharma (COPHF)
Creso Pharma brings pharmaceutical expertise and methodological rigor to the cannabis world and strives for the highest quality in its products. The company develops cannabis and hemp derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. Creso Pharma uses GMP (Good Manufacturing Practice) development and manufacturing standards as a reference of quality excellence with initial product registrations in Switzerland. It has worldwide rights for several unique and proprietary innovative delivery technologies, which enhance the bioavailability, and absorption of cannabinoids. The company is also progressing expansion opportunities into the North American recreational cannabis market through its wholly-owned subsidiary Mernova Medical Inc. ("Mernova Medical"
, as well as the emerging psychedelics sector through target acquisition company, Halucenex Life Sciences Inc. ("Halucenex" .
Click here:
https://stockhouse.com/news/press-releases/20...d-lab-tm-a
About Creso Pharma (COPHF)
Creso Pharma brings pharmaceutical expertise and methodological rigor to the cannabis world and strives for the highest quality in its products. The company develops cannabis and hemp derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. Creso Pharma uses GMP (Good Manufacturing Practice) development and manufacturing standards as a reference of quality excellence with initial product registrations in Switzerland. It has worldwide rights for several unique and proprietary innovative delivery technologies, which enhance the bioavailability, and absorption of cannabinoids. The company is also progressing expansion opportunities into the North American recreational cannabis market through its wholly-owned subsidiary Mernova Medical Inc. ("Mernova Medical"
, as well as the emerging psychedelics sector through target acquisition company, Halucenex Life Sciences Inc. ("Halucenex" .
(0)
(0)Scroll down for more posts ▼